Howard A. Burris
- Oncology top 0.01%
- Cancer Treatment and Pharmacology 178
- Colorectal Cancer Treatments and Studies 114
- HER2/EGFR in Cancer Research 113
- Lung Cancer Research Studies 81
- Cancer Research top 0.05%
- Pulmonary and Respiratory Medicine top 0.05%
- Lung Cancer Treatments and Mutations 130
- Advanced Breast Cancer Therapies 99
- Genetics top 0.1%
- Pathology and Forensic Medicine top 0.1%
-
- PI3K/AKT/mTOR signaling in cancer 79
- Cancer therapeutics and mechanisms 68
- Co-authors
- John D. HainsworthDaniel D. Von HoffSuzanne F. JonesF. Anthony GrecoAnna Maria StornioloMace L. RothenbergF. Andrew DorrJohn Sahl Andersen
- Journals
- Journal of Clinical Oncology (302 papers)Cancer Research (50 papers)Annals of Oncology (34 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Howard A. Burris
727 papers receiving 37.2k citations
Hit Papers
Peers
Comparison fields: 5 of 163
- Oncology 25.4k
- Cancer Research 6.2k
- Pulmonary and Respiratory Medicine 10.7k
- Genetics 2.9k
- Pathology and Forensic Medicine 3.8k
Countries citing papers authored by Howard A. Burris
This map shows the geographic impact of Howard A. Burris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard A. Burris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard A. Burris more than expected).
Fields of papers citing papers by Howard A. Burris
This network shows the impact of papers produced by Howard A. Burris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard A. Burris. The network helps show where Howard A. Burris may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Howard A. Burris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2021 | 56 | |
| 3 | 2019 | 64 | |
| 4 | 2018 | 62 | |
| 5 | Phosphatidylinositol 3-Kinase α–Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Studybreakdown → | 2018 | 302 |
| 6 | 2017 | 9 | |
| 7 | 2017 | 42 | |
| 8 | 2017 | 186 | |
| 9 | 2016 | 105 | |
| 10 | 2016 | 215 | |
| 11 | 2013 | 148 | |
| 12 | 2013 | 77 | |
| 13 | 2012 | 195 | |
| 14 | 2012 | 128 | |
| 15 | 2011 | 122 | |
| 16 | 2010 | 135 | |
| 17 | 2009 | 78 | |
| 18 | 2008 | 244 | |
| 19 | 2002 | 7 | |
| 20 | 2002 | 25 |
About Howard A. Burris
Howard A. Burris is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 741 papers that have together received 38.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (178 papers), Lung Cancer Treatments and Mutations (130 papers), Colorectal Cancer Treatments and Studies (114 papers), HER2/EGFR in Cancer Research (113 papers), Advanced Breast Cancer Therapies (99 papers), Lung Cancer Research Studies (81 papers), PI3K/AKT/mTOR signaling in cancer (79 papers) and Cancer therapeutics and mechanisms (68 papers). The work is most often cited by research in Oncology (25.4k citations), Cancer Research (6.2k citations) and Pulmonary and Respiratory Medicine (10.7k citations). Howard A. Burris has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include John D. Hainsworth, Daniel D. Von Hoff, Suzanne F. Jones, F. Anthony Greco, Anna Maria Storniolo, Mace L. Rothenberg, F. Andrew Dorr, John Sahl Andersen, M. Christine Cripps and Peter G. Tarassoff. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Cancer and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.